Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zurzuvae
Pharma
Beleaguered Sage bought for $561M
Supernus is buying Sage Therapeutics for $561 million, hoping that it can transform a new postpartum depression drug into a “standard of care."
Kevin Dunleavy
Jun 16, 2025 11:52am
As new launches take flight, 'a new Biogen' emerges, CEO says
May 1, 2025 11:55am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
Sage rebuffs Biogen's buyout offer, eyes strategic alternatives
Jan 27, 2025 3:03pm
Sage sues Biogen after receiving 'unsolicited' buyout offer
Jan 21, 2025 11:16am
Biogen looks to buy out neuro partner Sage
Jan 12, 2025 9:15pm
